# A Study Comparing Two Forms of Didanosine in HIV-infected Patients

> **NCT00002360** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 30 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Didanosine

## Key facts

- **NCT ID:** NCT00002360
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** 1999-03
- **Final completion:** 1999-03
- **Target enrollment:** 30 (—)
- **Last updated:** 2011-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002360, "A Study Comparing Two Forms of Didanosine in HIV-infected Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*